Myopia, also known as nearsightedness, occurs when the eyeball is too long, relative to the focusing power of the cornea and lens of the eye. This causes light rays to focus at a point in front of the retina, rather than directly on its surface. Generally, myopia first occurs in school-age children and progresses until about age 20. Myopia development is attributed to a combination of genetics and lifestyle factors, including increased screen time.
Until now, traditional eyeglasses and contact lenses available in the U.S. have only been developed to correct blurred vision, which is a symptom of myopia, while not approved to slow its progression.
Coopervision’s MiSight 1 day disposable soft contact lenses is FDA approved in children as young as 8 years of age to slow the progression of myopia. These contact lenses are worn during the day to help your child see clearly as well as delivering the treatment effect through their dual focus optical design. A 3 year clinical trial conducted by the manufacturer concluded the lens effectively slowed myopia progression by 59%
Children 8 years of age or older with advancing myopia as evidenced by changes to their glasses prescription are typically good candidates for MiSight.
At the initial consultation, we will discuss your child’s risk factors for myopia progression and if the MiSight contact lens is the right treatment modality. Then baseline measurements can be taken to fit your child with lenses, including training in lens use, storage, and care.